Filing
Spy
Filing
Spy
Home
About
VRTX
Vertex Pharmaceuticals Inc
Biopharmaceutical company
CUSIP: 92532F100
Healthcare
US
1 holder
Ownership
Activity
Fundamentals
2013 Q1
31 of 31 quarters
Total Value
$42.90M
Total Shares
780.5K
Net Share Change
+780.5K
Activity
1 buying
Investor
Value
Shares
Weight
Change
Viking Global Investors
$42.90M
780.5K
0.3%
NEW
Viking Global Investors
$42.90M
780.5K shares
NEW
VRTX — Vertex Pharmaceuticals Inc - FilingSpy